PMN ProMIS Neurosciences Inc.
Company Analysis
Latest News
ProMIS Neurosciences rated Overweight at Cantor Fitzgerald, eyes Alzheimer's trial data
Cantor Fitzgerald initiated research coverage of ProMIS Neurosciences (PMN) with an Overweight rating. The clinical-stage biotechnology firm develops antibody...
🟢 PMN makes sharp 13.0% jump
PMN is trading at $12.15, up 13.0% versus the comparison close of $10.75 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 PMN Dips 5.1% Amidst Broader Market Sell-off, Despite HC Wainwright & Co. Buy Rating Reiteration
PMN is trading 5.1% down at $10.15 today, pulling back from a multi-day climb, while major U.S. indices are broadly lower. * The decline comes despite H.C....
🟢 ProMIS Neurosciences Inc. is trading 5.1% up today following CEO summit presentation and Zacks upgrade
ProMIS Neurosciences Inc. is trading at $10.56 (up 5.1%), extending gains following a presentation by its CEO at the H.C. Wainwright Neuro Perspectives Expert...
🟢 ProMIS Neurosciences Inc. up 13.6% amid CEO's conference presentation and recent Zacks upgrade
• ProMIS Neurosciences Inc. is trading at $11.42 (13.6% up) in after-hours, rebounding from recent declines. • The company's CEO is presenting at the H.C....
🔴 ProMIS Neurosciences Inc. is trading 9.9% down today as it reverses an earlier technical rebound
ProMIS Neurosciences Inc. is trading at $9.19, down 9.9% in after-hours trading, as the stock reverses a technical bounce seen during the regular session. •...
🟢 ProMIS Neurosciences Inc. is trading 5.7% up today on technical rebound after recent volatility
ProMIS Neurosciences Inc. is trading 5.7% up today at $10.30, extending its recovery from last week’s sharp swings and a 6.17% decline on June 5. • The move...
🟢 ProMIS Neurosciences Inc. is trading 5.7% up today, extending its rebound from recent volatility
ProMIS Neurosciences Inc. is trading 5.7% up at $10.30, extending its rebound from last week’s volatility and a 6.17% drop on June 5. • The advance appears to...
🟢 ProMIS Neurosciences Inc. is trading 14.0% up today on a speculative rebound amid thin liquidity
ProMIS Neurosciences Inc. is trading 14.0% up today at $10.41, rebounding sharply after recent declines in early June despite a lack of new company-specific...
🟢 ProMIS Neurosciences Inc. is trading 7.2% up today on speculative rebound amid thin liquidity
ProMIS Neurosciences Inc. is trading 7.2% up today at $9.79 on a speculative rebound following a 6.2% decline on June 5, 2026. • The price action is currently...
🟢 ProMIS Neurosciences Inc. is trading 7.2% up today with no clear company-specific news catalyst
ProMIS Neurosciences Inc. is trading 7.2% up at $9.79 today, rebounding from a 6.2% decline in the previous session as it continues to fluctuate within a...
🟢 ProMIS Neurosciences Inc. is trading 5.9% up today despite broader market weakness
ProMIS Neurosciences Inc. is trading 5.86% up at $10.30 today, showing idiosyncratic strength as no specific company news or regulatory filings have been...
🟢 ProMIS Neurosciences Inc. is trading 5.9% up today on idiosyncratic move with no clear catalyst
ProMIS Neurosciences Inc. is trading 5.9% up today at $10.30 on relatively light, early-session upside following a period of recent volatility. • The move...